GSC
CBPO

Ground Swell Capital’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Ground Swell Capital’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-200
Closed -$9K – 3053
2014
Q2 		$9K Buy
+200
New +$8.17K 0.02% 810

Other funds holding CBPO

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EMR
Errol M. Rudman $148M AUM 19.65% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ground Swell Capital's CBPO Position: Q3 2014 in Review

Ground Swell Capital sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2014, closing a stake of 200 shares — an estimated $9K sold.

Ground Swell Capital first reported a position in CBPO in Q2 2014 and held it in 1 quarter. The position peaked at $9K in Q2 2014. 54 funds tracked by Wall St. Rank hold CBPO as of Q3 2014.

  • Ground Swell Capital reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 200 China Biologic Products Holdings, Inc. shares in Q3 2014, an estimated $9K.
  • Ground Swell Capital first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's China Biologic Products Holdings, Inc. position peaked at $9K in Q2 2014.
  • 54 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.